Chemomab Therapeutics (CMMB) Cash from Investing Activities Growth (3y) (2020 - 2023)

Chemomab Therapeutics (CMMB) Cash from Investing Activities Growth (3y) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 116.52%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 38.24%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Chemomab Therapeutics 852.08 Mn 841.71 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 732.35%
Sep 30, 2023 486.31%
Jun 30, 2023 -427.97%
Mar 31, 2023 1,030.60%
Dec 31, 2022 233.97%
Sep 30, 2022 195.56%
Jun 30, 2022 379.05%
Mar 31, 2022 223.20%
Dec 31, 2021 -809.82%
Sep 30, 2021 -219.02%
Jun 30, 2021 -625.29%
Mar 31, 2021 73.21%
Dec 31, 2020 27.89%